-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare
Overview ( as on 13/02/26 )
NAV
₹22.07
Last change
₹-0.3 -0.01%
Fund Size (AUM)
6658.41 Cr
Performance
16.09% (5Y)
Fund Details
ICICI Pru Pharma Healthcare Dg IDCW-R
as of 13/02/26
AUM
6658.41 Cr
Expense Ratio
1.86 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GG4
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Pru Pharma Healthcare Dg IDCW-R | 5.34% | 25.74% | 16.09% |
| BSE Healthcare TR INR | -1.09% | 22.5% | 14.92% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.2% |
Cipla Ltd |
9.43% |
Dr Reddy's Laboratories Ltd |
7.27% |
Mankind Pharma Ltd |
6.34% |
Divi's Laboratories Ltd |
6.22% |
Biocon Ltd |
5.85% |
Lupin Ltd |
4.8% |
Aurobindo Pharma Ltd |
3.91% |
Syngene International Ltd |
2.99% |
Alkem Laboratories Ltd |
2.9% |
Sector Allocation
Healthcare |
98.89% |
Basic Materials |
1.11% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
16.75% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
16.09% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.93% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.93% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.93% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
15.86% (5Y)
-
